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ABSTRACT
Objectives: To compare accuracy and assess agreement between intravoxel 
incoherent motion (IVIM) magnetic resonance (MR) perfusion-related parameters 
and quantitative dynamic contrast-enhanced (DCE) MR parameters in nasopharyngeal 
carcinoma (NPC).
Results: D, f, D*, Ktrans, Kep and Vp were significantly lower in the high stage group 
while Ve was significantly higher in the high stage group. Optimal cut-off values 
were: D=0.749 x 10-3 mm2/s; f=0.145; D*=100.401 x 10-3 mm2/s; Ktrans=0.571/
min; Kep=0.8196/min; Ve=0.6556 %; Vp=0.0757 %. D* (p=0.001), Ktrans (p<0.001), 
Ve (p=0.014) were all reliable independent predictors for AJCC staging. IVIM-MR 
perfusion-related (f, D*) and DCE-MR (Ktrans, Kep, Ve, Vp) parameters were significantly 
correlated (p<0.001).
Materials and Methods: 75 patients with newly diagnosed NPC were prospectively 
recruited. Diffusion-weighted MR and DCE-MR imaging were performed with respective 
IVIM (D, f, D*) and DCE (Ktrans, Kep, Ve, Vp) MR parameters calculated. Patients were 
stratified into low and high tumor stage groups according to American Joint Committee 
on Cancer (AJCC) staging for determination of the predictive powers of IVIM-MR and 
DCE-MR parameters using t–test, ROC curve analyses and multiple logistic regression 
analysis. Correlation between IVIM-MR perfusion-related and DCE-MR parameters 
was assessed using Spearman’s rank correlation.
Conclusion: IVIM-MR perfusion-related and quantitative DCE-MR parameters 
were significantly correlated in the assessment of NPC and were both reliable 
independent predictors in the prediction of AJCC staging. IVIM-MR perfusion imaging 
can be a potential useful non-invasive perfusion imaging tool for clinical use in the 
assessment of NPC.
www.impactjournals.com/oncotarget/              Oncotarget, 2017, Vol. 8, (No. 40), pp: 68472-68482
                                                        Research Paper
Oncotarget68473www.impactjournals.com/oncotarget
INTRODUCTION
Noninvasive diagnostic imaging and staging in 
nasopharyngeal carcinoma (NPC) is crucial in the early 
diagnosis and treatment planning, especially for patients 
with high stage disease requiring adjuvant therapy. Magnetic 
resonance (MR) imaging has been the gold standard and 
imaging of choice in the detection and delineation of local 
tumor extent [1–4]. Diffusion-weighted (DW) MR imaging 
allows additional information on the functional assessment 
and characterization of the tumor, showing promising 
results with successful differentiation between different 
tumor grading, rendering it an imaging biomarker.
Intravoxel incoherent motion (IVIM) MR imaging 
is one type of DW MR imaging technique receiving much 
attraction in that it provides with us both the diffusion and 
perfusion related information without the use of exogenous 
contrast. We have previously demonstrated that it is feasible 
in the differentiation between NPC and post-chemoradiation 
fibrosis [5], as well as in the pre-treatment staging prediction 
[6], showing high diagnostic accuracy. While the precision 
of the derived pure diffusion parameter, D (reflecting tissue 
cellularity) has been proven to be consistent with high 
diagnostic confidence, concern has been raised regarding 
the accuracy of the derived perfusion related parameters 
(perfusion fraction, f reflecting normal angiogenesis with 
intact vascular permeability; and pseudodiffusion coefficient, 
D* reflecting tumoral vascularity) given the limited signal-
to-noise ratio (SNR). The clinical utility of dynamic contrast 
enhanced (DCE) MR perfusion had been established in 
various tumors [7–10] as well as in NPC [11–13], with its 
quantitative analysis being found useful in the assessment 
of tumoral vascularity, microcirculation property and 
hypoxia status since the contrast kinetics is associated with 
angiogenesis within tumors. In particular, Ktrans (diffusive 
transport of Gd-DOTA across capillary endothelium/ volume 
transfer) and Ve (extracellular extravascular volume fraction) 
are frequently used to assess tumor outcomes as well as 
patient’s prognosis [14]. The relationship between IVIM-MR 
perfusion-related parameters and semi-quantitative DCE-
MR parameters had initially been tested in NPC, showing 
promising result [15]. However, the relationship between 
IVIM-MR perfusion-related parameters and quantitative 
DCE-MR parameters remains unexplored.
The aim of this study was to assess the correlation 
and agreement of the IVIM-MR perfusion-related 
parameters with the quantitative DCE-MR parameters, and 
to compare their diagnostic performance.
RESULTS
The mean tumor volume was 1702.8 mm3 +/− 
2012.9 mm3 (44.4 – 10098.6 mm3). The interobserver 
agreement showed good agreement with the kappa value 
(κ) for D, f, D*, Ktrans, Kep, Ve and Vp measured at 0.86, 
0.77, 0.70, 0.81, 0.76, 0.80 and 0.72 respectively.
IVIM DW-MR parameters
Both the diffusion (D) and perfusion-related 
parameters (f, D*) were statistically significantly lower in 
the high stage group as compared with low stage group in 
AJCC staging. Their respective mean values +/− standard 
deviation (SD) were summarized in Table 1. Respective 
optimal cut-off values upon ROC curve analyses (with 
respective sensitivity, specificity, positive likelihood ratio 
and negative likelihood ratio) were summarized in Table 2 
and were as follows: D=0.749 x 10-3 mm2/s (73.9%, 
93.1%, 10.72, 0.28); f=0.145 (76.1%, 75.9%, 3.15, 0.32); 
and D*=100.401 x 10-3 mm2/s (60.9%, 96.6%, 17.65, 
0.41); Respective ROC curves and areas under curves 
were represented in Figure 1. D was the most powerful 
parameter based on the area under curve (AUC=0.886).
DCE-MR parameters
Ktrans, Kep and Vp were all statistically significantly 
lower in the high stage group as compared with low stage 
group in AJCC staging. Ve on the contrary, was found to 
be positively correlated, showing statistically significantly 
higher value in the high stage group as compared with low 
stage group. Their respective mean values +/− SD were 
summarized in Table 1. Respective optimal cut-off values 
upon ROC curve analyses (with respective sensitivity, 
specificity, positive likelihood ratio and negative 
likelihood ratio) were summarized in Table 2 and were as 
follows: Ktrans=0.571 /min (97.8%, 96.6%, 28.37, 0.023); 
Kep=0.8196/min (91.3%, 86.2%, 6.62, 0.10); Ve=0.6556 % 
(87.0%, 89.7%, 8.41, 0.15); Vp=0.0757 % (84.8%, 93.1%, 
12.29, 0.16). Respective ROC curves and areas under 
curves were represented in Figure 2. Ktrans was the most 
powerful parameter based on AUC (0.996).
Comparison between IVIM-MR and DCE-MR 
parameters
Stepwise regression analysis revealed D (p<0.001), 
f (p=0.018), D* (p=0.001), Ktrans (p<0.001) and Ve 
(p=0.014) were all reliable independent predictors. Ktrans 
was statistically significantly more powerful than f and D* 
(p=0.001) on direct comparison. No statistical significance 
could be reached when Ve was compared against D, f and D*.
Correlation between IVIM and DCE-MR 
parameters
There was significant correlation between IVIM-MR 
perfusion-related parameters, f and D* with all DCE-MR 
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parameters, Ktrans, Kep, Ve and Vp (Spearman’s rank correlation 
coefficients: -0.628 to 0.533, p <0.001 (Bonferroni corrected 
p value = 0.002)). Their results were summarized and 
represented by scatter pots as shown in Figure 3.
DISCUSSION
Accurate staging in NPC is imperative for treatment 
planning as the differences in treatment paradigms and 
prognosis are based on tumor aggressiveness. This 
emphasizes the need for a noninvasive imaging tool that 
can help in the prediction of staging. IVIM MR imaging 
has been an attractive and promising alternative imaging 
tool that can simultaneously assess tissue vascularity and 
cellularity without the need of exogenous contrast. Despite 
the initial promising result of correlation between IVIM-
MR perfusion-related and semi-quantitative DCE-MR 
parameters, the relationship between IVIM-MR perfusion-
related and quantitative DCE-MR parameters remains 
unclear.
Our results are in concordance with other 
published data on NPC [11–15], showing similar 
range, trend and distribution of the parameters across 
different tumor stages. The improvement in results as 
compared with our earlier DCE-MR study on NPC [12] 
is likely attributed to the larger cohort of patients and 
Table 2: Optimal cut-off values under 95% confidence interval for AJCC staging according to ROC 
curves analysis, with p values from direct comparison of ROC curves (only positive comparisons 
are shown)

































































*AJCC = American Joint Committee on Cancer; CI = confidence interval; Pos LR = positive likelihood ratio; Neg LR = 
negative likelihood ratio“a” = Ktrans vs f; “b” = Ktrans vs D*;Bonferroni corrected p value = 0.002.
Table 1: Summarized mean values of the IVIM-MR parameters (D, f, D*) and DCE-MR parameters 
(Ktrans, Kep, Ve and Vp) with respective p values between low stage and high stage groups for AJCC 














































t-test p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001
* AJCC = American Joint Committee on Cancer.
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Figure 1: ROC curves analysis for IVIM-MR parameters with respective areas under curves in AJCC staging.
Figure 2: ROC curves analysis for DCE-MR parameters with respective areas under curves in AJCC staging.
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inclusion of wider spectrum of different tumor stages 
of NPC. Both the IVIM-MR parameters (D, f and D*) 
and DCE-MR parameters (Ktrans and Ve) were found to 
be reliable independent predictors in the prediction of 
AJCC staging. On direct comparison of their diagnostic 
accuracy, Ktrans was more robust as compared with f and 
D* (p=0.001). The robustness of quantitative DCE-
MR imaging (in particular for Ktrans) is likely attributed 
to its direct reflection of the tissue physiology based 
on the concentration of contrast and are more closely 
linked to perfusion and permeability, hence related to 
tumor angiogenesis [14]. The exact relationship between 
IVIM-MR perfusion-related parameters and DCE-MR 
parameters remains unclear, but is likely to demonstrate 
close correlation as Le Bihan et al. [16] reasoned that 
tracer delivery to tissue is dependent on intravascular flow. 
Our results confirmed that IVIM-MR perfusion-related 
parameters (f and D*) were significantly correlated with 
the quantitative DCE-MR parameters (Ktrans, Kep, Ve and 
Vp) (Spearman rank correlation p<0.001). This helped 
to suggest the usefulness of the IVIM-MR perfusion-
related parameters in that they are potentially reflecting 
the microvessel density or contrast kinetics as observed 
with the quantitative DCE-MR parameters, rendering it a 
potential useful non-invasive perfusion imaging tool in the 
assessment of angiogenesis or neovasculature in NPC.
High stage NPC exhibited significantly lower 
perfusion parameters (f, D*, Ktrans, Kep and Vp) as compared 
with low stage NPC, consistent with earlier IVIM-MR 
findings [5–6]. This can be attributed to the increasing 
tumoral heterogeneity due to the presence of microscopic 
necrosis or hypoxia in association with high stage NPC, 
as supported by prior studies showing reduced Ktrans with 
increasing hypoxia [17]. Sumi and Nakamura [18] also 
suggested that different stages of tumors would have 
distinctive stromal components with varying degrees 
of vascularization, and hence perfusion level, reflecting 
the relative area of stromal tissues with varying levels 
of vessel attenuation. Low stage NPC is less aggressive 
and has tightly packed stromal tissue due to the absence 
of necrosis, therefore increased vascularity overall. Our 
finding of higher Ve in high stage NPC suggests tumor 
Figure 3: Scatter plots and Spearman rank correlation coefficient with 2-tailed statistical significance (p value) between 
IVIM-MR parameters and DCE-MR parameters r = Spearman rank correlation coefficient. 
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aggression due to larger extracellular volume fraction. 
Although Ve reflects the extracellular extravascular space 
but not the vascular compartment, it had been found to 
correlate with tumor aggressiveness and played a role in 
stimulating angiogenesis as well as strengthening tumor 
cells migration into peripheral tissue [11, 14, 17]. Chin et 
al. [14] also hypothesized that tumor microenvironment 
with a large Ve would promote metastatic dissemination 
as it reflected the presence of abundant vascularized 
extracellular space.
The major limitation of our study is the lack of 
histopathological correlation such that the physiological 
basis of the perfusion status between different stages 
of NPC cannot be established. In particular, Ktrans does 
Figure 4: A 45-year-old male with stage T3 NPC. (A) Axial T2-weighted image showing region of interest (ROI) contouring the 
margin of the NPC, with subsequent co-registration of the ROI onto corresponding (B) diffusion map, D; IVIM MR perfusion related maps, 
(C) f and (D) D*; quantitative DCE MR perfusion maps, (E) Ktrans, (F) Kep, (G) Ve and (H) Vp.
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not necessarily linearly correlated to perfusion as it 
is also determined by the permeability of the blood 
vessels. Measurement reliability of both the IVIM-MR 
and DCE-MR perfusion parameters is another major 
challenge, given the intrinsic wide variability and SNR 
variation as reflected by the large SD and heterogeneous 
parametric maps accompanying f, D*, Ve and Vp [19, 20]. 
The extended Tofts model used in the analysis of DCE-
MR perfusion parameters is technically challenging, 
which can be confounded by many factors in both the 
acquisition and post-processing stages. In particular, the 
extremely low Vp value raises potential concern of over-
fitting and doubtfulness of its clinical use. In addition, 
it may not be able to sufficiently integrate the intricate 
microenvironment of biological tissues [13]. Estimations 
of IVIM-MR parameters are known to depend upon b-
value selection as different b values can result in higher 
or lower parameter estimations [21, 22]. The 13 b-values 
utilized in our study were based on our initial experience 
in our earlier studies, achieving reasonable results. We 
believe the use of optimal b-values distribution and 
signal averaging using ROI techniques have helped in 
achieving satisfactory results. The major drawback was 
the long duration of scanning time (12 minutes) of the 
DW sequence rendering it undesirable for clinical use. 
Future study can be directed on different combinations 
of b-values as to search for an optimal number or range 
for clinical utilization within a reasonable scanning time. 
Although we were able to demonstrate the feasibility and 
correlation of IVIM–MR perfusion related parameters, 
larger sample study is necessary to assess and confirm 
the diagnostic performance. Larger cohort from different 
tumor stages of NPC wound also be helpful to look for 
its discriminating power in individual tumor stages, in 
particular within same T stage.
In conclusion, we have demonstrated significant 
correlation between IVIM-MR perfusion-related 
parameters (f and D*) and quantitative DCE-MR 
parameters (Ktrans, Kep, Ve and Vp) in the assessment of 
NPC. D, f, D*, Ktrans and Ve were all found to be reliable 
independent predictors in the prediction of AJCC staging 
though Ktrans was more robust as compared with f and D* 
(p=0.001). IVIM-MR perfusion imaging can be a potential 
useful non-invasive perfusion imaging tool for clinical use 
in the assessment of NPC.
MATERIALS AND METHODS
Patient selection
A prospective study was carried out after 
institutional review board approval with written informed 
consent was obtained. Consecutive patients with newly 
diagnosed NPC seen in our institution from January 2012 
to March 2014 were recruited. Major inclusion criterion 
was patients with newly diagnosed biopsied proven NPC. 
Major exclusion criteria were: a) treatment of any form 
(surgery, chemoradiation) already given; b) concurrent 
nasopharyngeal disease or other tumors.
Eighty patients with newly diagnosed biopsied 
proven undifferentiated NPC were initially recruited. 
No other histological subtypes of NPC were identified. 
Five patients were excluded due to small tumor volumes 
(<30.00 mm3) or significant motion artifacts leading to 
inaccurate assessment. Therefore, a total of seventy-five 
patients (51 male, 24 female; mean age 53.0 +/− 13.4 
years, range 25-90 years) were included. American Joint 
Committee on Cancer (AJCC) and TNM stages for all 
patients were determined by two independent clinical 
oncologists subspecialized in NPC, based on all available 
imaging findings and endoscopic findings. Discrepancy if 
any, was resolved after subsequent consensus. Distribution 
of all patients’ respective AJCC and TNM stages together 
with their clinical demographic data were listed in Table 3.






Age (years) 53.0 ± 13.4 (25 - 90)
Tumor volume (mm3) 1702.8 ± 2012.9 (44.4 – 10098.6)
AJCC staging
 I 7 (9%)
 II 22 (29%)
 III 29 (39%)
 IV 17 (23%)
T staging
 T1 33 (44%)
 T2 15 (20%)
 T3 16 (21%)
 T4 11 (15%)
N staging
 N0 10 (13%)
 N1 28 (37%)
 N2 33 (44%)
 N3 4 (6%)
M staging
 M0 72 (96%)
 M1 3 (4%)
* AJCC = American Joint Committee on Cancer.
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MR imaging techniques
MR imaging were performed with a 3.0-T MR 
scanner (Achieva 3.0T, Philips Healthcare, Best, The 
Netherlands) utilizing a 16-channel neurovascular coil. 
Standard conventional sequences (axial T1-weighted turbo 
spin echo (TSE), axial T2-weighted short T1 inversion 
recovery (STIR), coronal T2-weighted STIR, 3D T1-
weighted turbo-field-echo (TFE) post-contrast scan) were 
initially performed.
DW MR imaging was subsequently performed 
using a fat-suppressed single-shot spin-echo echo-
planar imaging sequence with the following parameters: 
TR/TE=7996/43 ms; echo-planar imaging factor=35; 
sensitivity encoding factor=3.5; FOV=230 x 230 mm; slice 
thickness=3 mm; intersection gap=0.3 mm; matrix=128 
x 128; receiver bandwidth=2735.7 Hz per pixel; motion 
probing gradients in three orthogonal axes; number 
of signal averages=3; parallel imaging (SENSitivity 
Encoding [SENSE]) factor=3. A total of 13 b-values were 
used: 0, 10, 20, 30, 40, 60, 100, 120, 160, 200, 300, 500 
and 1000 s/mm2. The scanning time was about 12 minutes.
It was then followed by dynamic contrast enhanced 
MR imaging utilizing a 3D T1-weighted fast-field-
echo (FFE) sequence with 2 different flip angles [TR/
TE=4.8/2.4 ms; flip angle=50 for precontrast scan & 150 
for dynamic scan; FOV=230 x 230 mm; matrix=144 
x 144; 65 dynamic acquisitions; number of signal 
averages=4]. Intravenous bolus injection of 0.1 mmol/kg 
of body weight Gd-DOTA (Dotarem, Guerbet, France) 
was administered at the 8th dynamic acquisition at a rate 
of 3.5 mL/s by power injector followed by 25-mL saline 
flush. The scanning time was about 10 minutes.
Image analysis
Image analysis of the DW MRI data was performed 
using an in-house software program developed in IDL 
6.3 (ITT Visual Information Solutions, Boulder, CO) and 
fitted on a pixel-by-pixel basis by Levenberg-Marquardt 
algorithm, as described before [23–26]. DW images from 
all 3 directions were automatically averaged and used 
for analysis. The bi-exponential model from an IVIM 
sequence was described by Le Bihan [27] as Sb/S0= (1-f)
exp(-bD)+fexp[-b(D*+D)], where Sb is the signal intensity 
in the pixel with diffusion gradient b, S0 is the signal 
intensity in the pixel without diffusion gradient, D is the 
true diffusion as reflected by pure molecular diffusion, 
f is the fractional perfusion related to microcirculation, 
and D* is the pseudodiffusion coefficient representing 
perfusion-related diffusion or incoherent microcirculation. 
D was obtained by a simplified linear fit equation (Sb = 
S0 x exp-
b.D) using b values > 200 s/mm2; while f and D* 
were calculated by a nonlinear regression algorithm using 
all b values. Using Matlab (The MathWorks, Natick, 
Massachusetts), only pixels with signals safely above 
background noises were included for calculation to avoid 
fitting pixels with low SNR. Therefore, pixels with low 
SNR were removed from subsequent analysis.
Image analysis of the DCE MRI data was performed 
by in-house software program (DCE-Tool, Version 5.1, 
Philips Healthcare, Best, The Netherlands) based on a two-
compartment model (Extend Tofts model) [28, 29]. Motion 
correction and co-registration were initially performed 
and both the precontrast T1 map and dynamic T1 map 
were calculated as described previously [30, 31]. Based 
on the assumption of a linear relation between Gd-DOTA 
concentration and 1/T1, the Gd-DOTA concentration map 
was calculated. Arterial input function (AIF) was selected 
and obtained from the vertebral artery, with the parametric 
maps of Ktrans (diffusive transport of Gd-DOTA across 
capillary endothelium/ volume transfer), Kep (rate constant 
of Gd-DOTA/ reflux rate constant), Ve (extracellular 
extravascular volume fraction) and Vp (intravascular 
plasma volume fraction) generated automatically. Again, 
Using Matlab (The MathWorks, Natick, Massachusetts), 
only pixels with signals safely above background noises 
were included for calculation to avoid fitting pixels with 
low SNR. Any unphysiological data such as zero were 
excluded. Kinetic pharmacokinetic model fitting curves 
were used for validation of the data.
Region-of-interest (ROI) was manually drawn by 
two independent head-and-neck radiologists to contour 
the border of NPC on each slice of the axial STIR T2-
weighted images (Figure 4A), avoiding the inclusion of air 
and adjacent anatomic structures, such that the total tumor 
volume was analyzed. Total tumor volume was calculated 
using segmentation method as described previously [32]. 
It was then co-registered to the diffusion (Figure 4B) and 
perfusion (Figure 4C-4H) maps for subsequent analysis 
using Image J (NIH, Bethesda, MD). Each lesion was 
measured twice in two separate sessions at 2 weeks apart 
to ensure reproducibility. The obtained IVIM-MR and 
DCE-MR parameters for each tumor were calculated on 
a pixel-by-pixel basis and expressed as mean values of all 
pixels within the volume of interest.
Statistical analysis
Patients were stratified into two groups for the 
evaluation of AJCC stage by combining AJCC stage I and 
II (n=29) into low stage group, and AJCC stage III and IV 
(n=46) into high stage group for statistical analysis.
Normality test was performed using Shapiro-
Wilk test, with the DCE and IVIM parameters showing 
approximately normal distribution (all P>0.05). Univariate 
analysis using Student’s t-test was performed to compare 
IVIM-MR parameters (D, f, D*) and DCE-MR parameters 
(Ktrans, Kep, Ve and Vp) between low and high AJCC stages. 
Multiple logistic regression analysis was performed to 
gauge their independent predictive values. Receiver 
operating characteristic (ROC) curves were derived with 
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respective cut-off values determined to accommodate 
best diagnostic accuracy. Comparison of the accuracy 
of different ROC curves was carried out by given p 
values. Correlation between IVIM-MR perfusion-related 
parameters and DCE-MR parameters were determined by 
using Spearman’s rank correlation. All statistical analyses 
were performed by SPSS version 21 (SPSS Inc, Chicago, 
IL, USA). Bonferroni correction was performed to account 
for the multiple comparisons.
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